Nitrous oxide inhalation induced Vit B12 deficiency myeloneuropathy

Paraparesis after Nitrous oxide inhalation/myeloneuropathy due to Vit B12 deficiency

Causes of Vit B12 deficiency: pernicious anemia due to autoimmune parietal cell dysfunction, associated with defective gastric secretion and absence of intrinsic factor; inadequate dietary intake (vegans), atrophy of the gastric mucosa, parietal or total gastrectomy, functionally abnormal intrinsic factor, inadequate hydrolysis of dietary cobalamin, insufficient pancreatic protease, bacterial overgrowth in the intestine, terminal ileum disease, tropical sprue, genetic enzyme deficiencies (methylmalonic aciduria), tapeworm infestation, disorders of plasma transport of cobalamin, dysfunctional uptake and use of cobalamin by cells, drugs such as metformin, PPI, and nitrous oxide administration. 

Nitrous oxide (N2O) is widely used as a propellant in the food industry (whipped cream dispenser - whippet/whip-it).  It is also widely used as in anesthesia.  It is a potent antioxidant that has multiple deleterious effects on cobalamin metabolism.  In humans, the use of N2O is associated with neurologic and hematologic manifestations.  Patients with cobalamin deficiency may be particularly susceptible to brief exposures to nitrous oxide, which inactivates cobalamin-dependent methionine synthase and may cause a myeloneuropathy.  In healthy subjects, this side effects on the methionine synthase methlcobalamin complex may be well compensated for by the large vitamin B12 deficiency, even a short course of nitrous oxide anesthesia may deplete the few remaining stores.  

Symptoms:

DDx:  Neurosyphilis, disseminated tuberculosis, HIV associated infections, SLE, neurosarcoidosis, acute disseminated encephalomyelitis, multiple sclerosis, nitrous oxide, vitamin B12 deficiency, vitamin D, E, copper, and folate deficiencies.  Malabsorption syndromes (UC).  

Laboratory and diagnostic:

Treatment:

Copper  deficiency also mimic Vit B12 deficiency induced myelopathy:

Vitamin B12 deficiency as a cause of polyneuropathy remains a common phenomenon.  Patients typically present with sensory neuropathy and a myelopathy called subacute combined degeneration (SCD) a term that is descriptive for the pathology of the dorsal column, cortical spinal tract, and peripheral nerves.  Patients typically lose vibration and joint position sense in the toes and ankles, hyperreflexia in the upper extremities and knees, and absent ankle reflexes.   Neuropathologically, patients have a large fiber neuropathy and atrophy of the dorsal column and the corticospinal tracts.  Hematologic studies show a megaloblastic anemia with an elevated MCV and hypersegmented PMN count.  Serum levels of Vit B12 below 100 pg/mL should be considered suspicious for the diagnosis. They should be considered suspicious for the diagnosis and should lead to further testing if the patient has a polyneuropathy.  Elevated MMA and homocysteine levels help to support the diagnosis. 

Copper deficiency causes a similar process as Vitamin B12 deficiency.  If the disease is severe or untreated for long periods, patients manifest lower extremity paresthesia, leg weakness, gait ataxia, and spasticity.  Similar to SCD, patients have myelopathy and peripheral neuropathy, clinically and electrodiagnostically.  The anemia associated with copper deficiency is microcytic and is associated with neutropenia and sometimes pancytopenia.  IV copper reverses the hematological, but not the neurologic manifestations of the illness.  Several cases of copper deficiency neuropathy and anemia have been described in patients who have since toxicity as high zinc levels lead to copper deficiency.  Some denture creams are known to contain large amounts of zinc and some patients were using large amounts of denture creams to secure their dentures.  For this reason patients with low copper levels should be screened for zinc toxicity. 

Subacute Combined Degeneration of the Spinal Cord - StatPearls - NCBI Bookshelf (nih.gov) 

Vitamn B12 deficiency